Macugen

Macugen Pegaptanib
Pegaptanib Sodium Injection (brand Name Macugen) Is An Anti-angiogenic Medicine For The Treatment Of Neovascular (wet) Age-related Macular Degeneration (amd). It Was Discovered By Gilead Sciences And Licensed In 2000 To Eyetech Pharmaceuticals, Now Osi Pharmaceuticals, For Late Stage Development And...

Macugen
Last Updated: Friday, 6/3/2005 6:23:13 AM

Macugen Lucentis
masculen degeneration
Last Updated: Monday, 9/26/2005 9:35:04 PM

Can't Find What You're Looking For? Submit a Topic Below 

No registration is required - simply follow the 4 short steps below for your post to appear on the home page. People will be able to post replies back to you, sharing any information or common experiences. Your topic will be added to the community for everyone to locate & read. If you need help identifying a drug: Post the Shape, Color, and ALL Letters, Numbers, and Markings which appear on the pill. Specify whether it is a Pill, Tablet, Capsule, etc. Please be as detailed as possible. 1) Title / Subject: *  This should be a summary / headline of what you are posting, and it is first thing that anybody sees. 2) Detailed Description: *  PLEASE BE AS DETAILED AS POSSIBLE. You will increase your chances of getting a  faster reply by being as specific as possible.  The more information you include, the better!      3) Email Address (optional - stays hidden):  Providing an email address allows you to receive alerts whenever somebody posts a reply to you. Subscribe to Health News Daily Newsletter - Top headlines emailed to you each evening 4) Enter the Security Code (Case Sensitive):  Used to prevent forum spam and abuse.     Legal & Privacy Notes - Posts are subject to editing and may not appear immediately. There may be a delay for your post to appear on the home page. - Your identity remains anonymous (even from us). Providing an email address allows you to receive automatic notifications of replies. - Posting to the community does NOT subscribe you to an email list UNLESS you select the above option to receive the daily newsletter. - You agree to be bound by this site's Terms of Use.

Search Tips: